BioMarin appoints Robert Plenge to board and committee
BioMarin said Robert Plenge, M.D., Ph.D., was appointed to its Board of Directors and the Science and Technology Committee, effective September 10, 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
5 results loaded, newest first. End of these results.
BioMarin appoints Robert Plenge to its board
BioMarin appointed Robert Plenge, EVP and Chief Research Officer at Bristol Myers Squibb, to its Board of Directors, effective Sept. 10, 2026.
BioMarin appoints Robert Plenge to board
BioMarin appoints Robert Plenge to board
BioMarin appoints Robert Plenge to board
BioMarin said it appointed Robert Plenge, M.D., Ph.D., to its board of directors effective September 10, 2026.